Apollo Medical Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Variable Interest Entities (VIEs) (Tables)

Variable Interest Entities (VIEs) (Tables)

3 Months Ended

Mar. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

The following table includes assets that can only be used to settle the liabilities of APC and the creditors of APC have no recourse to the Company. These assets and liabilities, with the exception of the investments in other entities cost method and amounts due to affiliate, which are eliminated upon consolidation with the NMM, are included in the accompanying consolidated balance sheets.

	March 31, 2018		December 31, 2017

Assets

Current assets
Cash and cash equivalents	$	58,024,188	$	54,686,370
Restricted cash short-term		18,028,116		18,005,661
Fiduciary cash		1,386,474		2,017,437
Investment in marketable securities		1,061,022		1,057,090
Receivables, net		38,844,184		15,183,483
Prepaid expenses and other current assets		1,960,737		1,821,328

Total current assets		119,304,721		92,771,369

Noncurrent assets
Land, property and equipment, net		10,201,045		10,167,689
Intangible assets, net		67,670,837		70,841,907
Goodwill		60,012,316		60,012,316
Loans receivable related parties		5,000,000		5,000,000
Loan receivable		5,000,000		5,000,000
Investments in other entities equity method		21,875,500		21,903,524
Investments in other entities cost method		4,320,000		4,320,000
Restricted cash long-term		745,293		745,235
Other assets		1,155,114		1,371,664

Total noncurrent assets		175,980,105		179,362,335

Total assets	$	295,284,826	$	272,133,704
Current liabilities
Accounts payable and accrued expenses	$	3,505,047	$	3,625,610
Incentives payable		14,900,000		21,500,000
Fiduciary accounts payable		1,386,474		2,017,437
Medical liabilities		25,212,116		25,186,240
Income taxes payable		3,229,058		1,463,540
Amount due to affiliate		28,061,953		24,889,717
Bank loan, short-term		394,783		510,391
Capital lease obligations		99,480		98,738

Total current liabilities		76,788,911		79,291,673

Noncurrent liabilities
Deferred tax liability		27,406,818		20,970,766
Liability for unissued equity shares		1,185,025		1,185,025
Capital lease obligations, net of current portion		593,852		619,001

Total noncurrent liabilities		29,185,695		22,774,792

Total liabilities	$	105,974,606	$	102,066,465

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details